Adverum Biotechnologies to Present at the 2018 Jefferies Global Healthcare Conference
MENLO PARK, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced today that Leone Patterson, interim …